Endocrine Disruptors and Breast Cancer: A Comprehensive Review.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data
PubMed 41301867 · doi:10.3390/biomedicines13112774
What was done
Narrative review evaluating the mechanistic links and health consequences associated with exposure to endocrine-disrupting chemicals (EDCs)—including polychlorinated biphenyls, parabens, phenols, dioxins (TCDD), phthalates (DEHP), and bisphenol A—in relation to breast cancer, alongside European Union regulatory guidelines.
What was found
The abstract reports no quantitative estimates or pooled numerical findings. It qualitatively describes how EDCs interact with estrogen, progesterone, aryl hydrocarbon, and thyroid-stimulating hormone receptors to disrupt endocrine synthesis, secretion, and metabolism, thereby potentially promoting breast cancer initiation and progression.
Why it matters
Provides an overview of how ubiquitous environmental chemicals may interfere with hormonal signaling pathways relevant to breast tissue biology and cancer risk.
Limits
As a narrative review, it lacks systematic search criteria, structured study selection, and quantitative meta-analysis. No original human or experimental data are presented in the abstract.
Cited by
- supports Environmental chemicals in plastics such as BPA mimic estrogen in the human body.